12%
y impact the lives of patients in their most anxious times and turn their anxiety into assurance 12% CAGR revenue growth in last 7 years 212 Clinical Labs 4,000+ Tests & Profiles 35 ISO:15189
rs
212
most anxious times and turn their anxiety into assurance 12% CAGR revenue growth in last 7 years 212 Clinical Labs 4,000+ Tests & Profiles 35 ISO:15189 Accredited Labs (31 in India / 4 in Kenya) 2
INR 425
a Pathology, Kolhapur – 18 September 2025 Q4 & FY26 Key Financials – MHL Group Q4FY26 Revenue INR 425 Cr +23% YoY EBITDA PAT INR 108 Cr +71% YoY* INR 51 Cr +75% YoY Revenue INR 1,646 Cr +24
23%
Kolhapur – 18 September 2025 Q4 & FY26 Key Financials – MHL Group Q4FY26 Revenue INR 425 Cr +23% YoY EBITDA PAT INR 108 Cr +71% YoY* INR 51 Cr +75% YoY Revenue INR 1,646 Cr +24% YoY
INR 108
er 2025 Q4 & FY26 Key Financials – MHL Group Q4FY26 Revenue INR 425 Cr +23% YoY EBITDA PAT INR 108 Cr +71% YoY* INR 51 Cr +75% YoY Revenue INR 1,646 Cr +24% YoY FY26 EBITDA INR 401 Cr +3
71%
FY26 Key Financials – MHL Group Q4FY26 Revenue INR 425 Cr +23% YoY EBITDA PAT INR 108 Cr +71% YoY* INR 51 Cr +75% YoY Revenue INR 1,646 Cr +24% YoY FY26 EBITDA INR 401 Cr +32% YoY*
INR 51
inancials – MHL Group Q4FY26 Revenue INR 425 Cr +23% YoY EBITDA PAT INR 108 Cr +71% YoY* INR 51 Cr +75% YoY Revenue INR 1,646 Cr +24% YoY FY26 EBITDA INR 401 Cr +32% YoY* PAT INR 191
75%
MHL Group Q4FY26 Revenue INR 425 Cr +23% YoY EBITDA PAT INR 108 Cr +71% YoY* INR 51 Cr +75% YoY Revenue INR 1,646 Cr +24% YoY FY26 EBITDA INR 401 Cr +32% YoY* PAT INR 191 Cr +31%
INR 1,646
Revenue INR 425 Cr +23% YoY EBITDA PAT INR 108 Cr +71% YoY* INR 51 Cr +75% YoY Revenue INR 1,646 Cr +24% YoY FY26 EBITDA INR 401 Cr +32% YoY* PAT INR 191 Cr +31% YoY 4 * E B I T D A f
24%
5 Cr +23% YoY EBITDA PAT INR 108 Cr +71% YoY* INR 51 Cr +75% YoY Revenue INR 1,646 Cr +24% YoY FY26 EBITDA INR 401 Cr +32% YoY* PAT INR 191 Cr +31% YoY 4 * E B I T D A f o r Q 4
INR 401
PAT INR 108 Cr +71% YoY* INR 51 Cr +75% YoY Revenue INR 1,646 Cr +24% YoY FY26 EBITDA INR 401 Cr +32% YoY* PAT INR 191 Cr +31% YoY 4 * E B I T D A f o r Q 4 & F Y 2 5 i s i n c l . o n e
32%
Cr +71% YoY* INR 51 Cr +75% YoY Revenue INR 1,646 Cr +24% YoY FY26 EBITDA INR 401 Cr +32% YoY* PAT INR 191 Cr +31% YoY 4 * E B I T D A f o r Q 4 & F Y 2 5 i s i n c l . o n e o f e x